ZimVie (ZIMV) said Friday that it is withdrawing its fiscal 2025 guidance as it prepares to go private following a recently announced $731 million acquisition deal with Archimed.
The deal is slated to be completed by the end of this year.
ZimVie said it will report Q2 financial results and file its quarterly report on Form 10-Q after market close on July 30.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.